Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
2013-004460-66Phase 4Completed
Phase 4, single-arm trial of potassium chloride in Abnormality of blood pressure regulation and hypertension (HTN), sponsored by Jørgen Jeppesen. Primary endpoint: Angiotensin II stimulated S-aldosterone. Started Mar 2014; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on 2013-004460-66.